Biological Specialty Company (BSC) Revenue and Competitors
Estimated Revenue & Valuation
- Biological Specialty Company (BSC)'s estimated annual revenue is currently $4.3M per year.
- Biological Specialty Company (BSC)'s estimated revenue per employee is $155,000
Employee Data
- Biological Specialty Company (BSC) has 28 Employees.
- Biological Specialty Company (BSC) grew their employee count by 22% last year.
Biological Specialty Company (BSC)'s People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | Production And Quality Manager | Reveal Email/Phone |
3 | Center Manager | Reveal Email/Phone |
4 | President | Reveal Email/Phone |
5 | Administrative Assistant | Reveal Email/Phone |
6 | Donor Recruiter | Reveal Email/Phone |
7 | Medical Laboratory Technician | Reveal Email/Phone |
Biological Specialty Company (BSC) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Biological Specialty Company (BSC)?
Biological Specialty Company (BSC) supplies the scientific community with human biologicals collected at our own regulated and IRB-approved donor centers. Products include blood, plasmas and sera, as well as white blood cells, red blood cells, and various other human samples
keywords:N/AN/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.3M | 33 | -6% | N/A |
#2 | $7.1M | 39 | 3% | N/A |
#3 | $9.3M | 40 | 0% | N/A |
#4 | $11.2M | 51 | 0% | N/A |
#5 | $10.9M | 67 | 5% | N/A |